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Injuries caused by brown spiders (Loxosceles genus) are asso-
ciated with dermonecrotic lesions with gravitational spreading
and systemic manifestations. The venom has a complex compos-
ition containing many different toxins, of which metalloproteases
have been described in many different species of this genus.
These toxins may degrade extracellular matrix constituents acting
as a spreading factor. By using a cDNA library from an
Loxosceles intermedia venom gland, we cloned and expressed a
900 bp cDNA, which encoded a signal peptide and a propeptide,
which corresponded to a 30 kDa metalloprotease, now named
LALP (Loxosceles astacin-like protease). Recombinant LALP
was refolded and used to produce a polyclonal antiserum, which
showed cross-reactivity with a 29 kDa native venom protein. CD
analysis provided evidence that the recombinant LALP toxin
was folded correctly, was still in a native conformation and
had not aggregated. LALP addition to endothelial cell cultures
resulted in de-adhesion of the cells, and also in the degradation of
fibronectin and fibrinogen (this could be inhibited by the presence
of the bivalent chelator 1,10-phenanthroline) and of gelatin in
vitro. Sequence comparison (nucleotide and deduced amino acid),
phylogenetic analysis and analysis of the functional recombinant
toxin revealed that LALP is related in both structure and function
to the astacin family of metalloproteases. This suggests that an
astacin-like toxin is present in a animal venom secretion and
indicates that recombinant LALP will be a useful tool for future
structural and functional studies on venom and the astacin family.
Key words: astacin, Loxosceles astacin-like protease (LALP),
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INTRODUCTION
Injuries caused by spiders of the genus Loxosceles (brown spiders)
typically result in necrotic skin lesions and some systemic-level
symptoms, including intravascular haemolysis, acute renal failure
and disseminated intravascular coagulation [1,2].
Brown spiders have a worldwide distribution and have been
found in Europe, America, Asia, Australia and Africa. Some
explanation for this general flourishing may be offered by the
biology of these spiders. They survive in adverse conditions,
withstand temperatures ranging from 8 to 43 ◦C [1] and have a pre-
dilection towards both dead scavenged prey and live prey [3].
Loxoscelism or necrotic arachnidism are the names used to de-
scribe lesions and symptoms induced by bites from spiders of the
Loxosceles genus. Loxoscelism is indicated by a dermonecrotic
lesion with gravitational spreading [1,2]. The mechanism by
which the venom causes dermonecrosis is currently under in-
vestigation. There is evidence for the role of an inflammatory res-
ponse, involving neutrophils and other leucocytes, which triggers
aseptic coagulative tissue necrosis [4,5]. This inflammatory
response seems to be dependent on an endothelial cell agonist
effect caused by the venom that triggers indirect and dysregulated
leucocyte activation [6]. Several constituents of Loxosceles spider
venom have been identifed previously, including hyaluronidases,
serine proteases, metalloproteases and phospholipase D family
members [1,2,7–12]. Of these constituents, phospholipase D,
also called dermonecrotic toxin, can induce red blood cell
haemolysis, platelet aggregation, renal disturbances, macroscopic
dermonecrosis and diffuse inflammatory response at the site of
injection under laboratory conditions [1,13,14]. Today, it is well-
established that phospholipase D comprises a family of toxins
present in several Loxosceles species and exists as different
isoforms [1,10,11].
Metalloproteases in Loxosceles venom were first identified
in Loxosceles intermedia. Feitosa et al. [7], working with
eletrostimulated venom, described two molecules in the venom
with fibronectinolytic, fibrinogenolytic (20–28 kDa molecule)
and gelatinolytic (32–35 kDa molecule) activity. Metalloprotease
activity in the venom was studied further by da Silveira et al. [15],
who showed the same metalloprotease-dependent fibronectino-
lytic, fibrinogenolytic and gelatinolytic activities in extracts
from L. intermedia and Loxosceles laeta gland venom. Addi-
tionally, Zanetti et al. [16] described this fibrinogenolytic and
metalloprotease-dependent activity in venom from Loxosceles
gaucho and L. laeta, and purified a 30 kDa molecule with
fibrinogenolytic activity from L. intermedia venom. The action
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of L. intermedia venom on fibrinogen was demonstrated to have
a complete cleaving effect on denatured fibrinogen, compared
with a partial cleavage activity on intact fibrinogen (α and β
chains), suggesting that susceptibility to the venom was due
to the conformation of the substrate. There have also been
metalloproteases identified in Loxosceles rufescens venom which
possess caseinolytic, gelatinolytic and fibrinogenolytic activ-
ities [9].
In the present paper, we report the identification, cloning,
expression, purification and functional characterization of a
metalloprotease characterized as an astacin-like toxin isolated
from the L. intermedia venom gland. These results strengthen
the previous data that described metalloproteases in Loxosceles
venoms and indicate for the first time the presence of an astacin-
like enzyme as a venom toxin constituent.
EXPERIMENTAL
Materials and reagents
Polyclonal antibodies against L. intermedia crude venom toxins
and the recombinant toxin, LALP (Loxosceles astacin-like
protease), were produced in rabbits as described previously
[17,18]. Crude venom from L. intermedia was extracted from
wild-caught spiders following the method in Feitosa et al. [7].
Fibronectin was purified from fresh human plasma by affinity
chromatography on gelatin-Sepharose (Sigma) [19]. Human
fibrinogen and gelatin were also purchased from Sigma.
cDNA library construction
The venom gland cDNA library was constructed as described by
Chaim et al. [14]. Briefly, venom gland mRNAs from 200 adult L.
intermedia spiders were purified using the FastTrack 2.0 mRNA
isolation kit (Invitrogen). The cDNAs were then synthesized using
the SuperScript Plasmid System with Gateway Technology for
cDNA Synthesis and Cloning (Invitrogen), cloned into NotI and
SalI pre-cut pSPORT1 vector and transformed into Escherichia
coli DH5α cells. Transformants were selected on LB (Luria–
Bertani) agar plates containing 100 µg/ml ampicillin.
cDNA library screening
Randomly chosen colonies (approx. 100 clones) were inoculated
into LB broth containing 100 µg/ml ampicillin and grown
overnight at 37 ◦C (with aeration). From this, recombinant
plasmids were purified using QIAprep Spin Miniprep Kit
(Qiagen). The cloned cDNAs were sequenced on both strands
using ABI PRISM® BigDye Terminator Cycle Sequencing
Ready Reaction Kit (Applied Biosystems). Reactions were
analysed using an ABI 377 automatic sequencer (Applied
Biosystems). The T7 and SP6 promoter regions were used for
priming the sequencing reactions. The cDNA sequences were
analysed, and the putative protein products from these sequences
were used to search the GenBank® protein databases on the
NCBI (National Center for Biotechnology Information) website
(http://www.ncbi.nlm.nih.gov/) [20].
Recombinant protein expression
cDNA encoding for the putative mature metalloprotease toxin
LALP was amplified by PCR using Pfu DNA polymerase (Fer-
mentas). The forward primer used was 5′-CGCGTCGACAATG-
CTGTCAAATATGACCAG-3′ and the reverse primer was
5′-CGGGATCCTCACACATTTACATACGGACGT-3′. The for-
ward primer contained a SalI restriction site (underlined) at
the 5′ end, and the reverse primer contained an engineered
BamHI restriction site (underlined) and the native stop codon
(in bold) of the cDNA. The PCR product was digested using
SalI and BamHI and gel-purified using the PerfectPrep Gel
Cleanup kit (Eppendorf) The purified DNA was subcloned into
pET-14b (Novagen) and digested with XhoI and BamHI. The
correct construct was confirmed by PCR and sequencing. The re-
combinant construct was subsequently expressed as a fusion
protein, with a 6 × His tag and a 13-amino-acid linker, including a
thrombin site, at the N-terminus. The final construct was the first
asparagine residue of mature LALP preceded by a 6 × His tag
and a thrombin site. The expression construct was transformed
into E. coli BL21(DE3)pLysS competent cells and plated on to
LB agar plates containing 100 µg/ml ampicillin and 34 µg/ml
chloramphenicol. Single colonies of LALP were used to inoculate
LB broth (100 µg/ml ampicilin and 34 µg/ml chloramphenicol)
and grown overnight at 37 ◦C. These cultures were diluted
1:100 into 1 litre of fresh LB broth containing ampicillin and
chloramphenicol, and incubated at 37 ◦C until the D550 reached
0.5. Recombinant expression was induced by the addition of
IPTG (isopropyl β-D-thiogalactoside) to a final concentration
of 0.05 mM, and cells were incubated for 4 h at 37 ◦C with
vigorous shaking. Cells were harvested by centrifugation at
4000 g for 7 min at 4 ◦C, before being resuspended in 40 ml
of a denaturing lysis buffer (20 mM sodium phosphate, pH 7.8,
500 mM NaCl and 6 M guanidinium chloride) and frozen at
−20 ◦C overnight.
Protein purification and refolding
Cell suspensions were thawed, and the lysed material was clarified
by centrifugation at 9000 g for 30 min at 4 ◦C. The supernatants
were incubated with 1 ml of Ni-NTA (Ni2+-nitrilotriacetate)–
agarose beads for 30 min at room temperature (25 ◦C), with
gentle agitation. The suspensions were loaded on to a column,
and the packed gel was exhaustively washed with the following
buffer (20 mM sodium phosphate, pH 8.0, 500 mM NaCl, 8 M
urea and 20 mM imidazole). The recombinant protein was then
eluted in 10 ml of elution buffer (20 mM sodium phosphate,
pH 8.0, 500 mM NaCl, 8 M urea and 250 mM imidazole),
and 1 ml fractions were collected and resolved by SDS/PAGE
(12.5% gels) under reducing conditions. Fractions were pooled
and dialysed against 10 mM sodium phosphate buffer (10 mM
Na2HPO4/NaH2PO4, pH 7.4), for 16 h. After dialysis, the refolded
recombinant protein was recovered from the supernatant by
centrifugation at 9000 g for 30 min at 4 ◦C and quantified [21].
CD spectroscopy
For measurement of CD spectra, recombinant LALP was dialysed
at 4 ◦C for 16 h against 10 mM sodium phosphate buffer, pH 7.4,
and spectra were recorded in a Jasco J-810 spectropolarimeter
(Jasco Corporation) using a 1 mm gap cuvette. Each spectrum
(0.5 nm interval) was the average of eight measurements,
performed at a rate of 50 nm/min using a response time of 8 s
and a bandwidth of 1 nm. The temperature was kept constant
at 25 ◦C. The secondary structures of the toxin were estimated
from the spectra using the Contin method and the Self-consistent
method as provided in Dicroprot 2000 1.0.4 software [22] (see
Table 1).
Animals
Adult rabbits (weighing approx. 3 kg) from the Central Animal
House of the Federal University of Parana´ were used for in vivo
experiments (production of polyclonal antibodies) using both
crude venom and recombinant toxin. All experimental protocols
using animals were performed according to the Principles of
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Table 1 Secondary-structure estimation of LALP by using CD spectro-
photometry and deconvolution of spectra using Dichroprot 2000 1.0.4
software
Estimated secondary structure of LALP (%)
Method α-Helix β-Sheet β-Turn Other
Self-consistent method 19.3 27.2 22.2 31.2
Contin method 19.0 27.0 – 54.0
Laboratory Animal Care [NIH (National Institutes of Health)
Publication number 85–23, revised 1985], Brazilian Federal
Laws and Ethical Committee Agreement number 126 of
Federal University of Parana´.
Gel electrophoresis, immunoblotting and ELISA
The protein concentration of samples was determined using the
Coomassie Blue method (Bio-Rad), and experiments were
performed five times. Protein concentration measurement was
also done using the protein guanidine-denaturation method (6 M
guanadinium chloride and 20 mM phosphate buffer, pH 6.5) and
measurement at 280 nm. Consistent results were obtained using
both methods. For protein analysis, SDS/PAGE (12.5% gels) was
performed under reducing conditions, and, for protein detection,
gels were stained with Coomassie Blue. For immunoblotting,
proteins were transferred on to nitrocellulose filters overnight
and immunostained with hyperimmune antisera, which reacts
with LALP, or against crude venom toxins (as described above).
Molecular-mass markers were purchased from Sigma. Antibody-
capture ELISAs were performed as follows. Crude venom or
purified recombinant toxin (10 µg/ml) was bound to the plate
bottoms (Nunc MaxiSorp) for 2 h at room temperature under
humid conditions. The plates were washed with PBS, and the
remaining sites for protein binding on the plates were saturated
with blocking buffer [3% (w/v) BSA in PBS] for 2 h at room
temperature. After washing the plates with PBS, the primary
antisera (against crude venom toxins or LALP) were incubated
for 2 h at room temperature. The plates were then incubated with
secondary antibodies conjugated to HRP (horseradish peroxidase)
for 1 h at room temperature, and the colorimetric reaction
was developed using OPD (o-phenylenediamine dihydrochloride)
[17].
Cell culture conditions and LALP cytotoxicity
Rabbit subendothelial cells which were used in this study were
maintained in liquid nitrogen with a low number of passages.
After thawing, the cells were grown in monolayer cultures in
RPMI 1640 medium containing penicillin (10000 IU/ml) and
supplemented with 10% FCS (fetal calf serum). The cultures
were incubated at 37 ◦C in a humidified atmosphere containing
5% CO2. Release of the cells from the dish was performed
by treating cells with 0.25% pancreatin for 10 min. After cell
counting, the cells were resuspended in 10 ml of medium and
evaluated for cytotoxic effects in the presence or absence of
LALP (5 µg/ml). Plates were photographed at 3 and 16 h after
resuspension using an inverted microscope (Leica-DMIL), and
changes in cell morphology were evaluated. Experiments were
performed in triplicate.
Proteolytic effect of LALP on fibronectin, fibrinogen and gelatin
Human plasma fibronectin and human fibrinogen were incubated
with LALP at a substrate/recombinant toxin ratio of 25:1 at
37 ◦C for 16 h. Negative-control substrates were incubated
at 37 ◦C for 16 h in the absence of recombinant toxin. As an added
control, we incubated protein substrates under similar conditions
as described above, but with a recombinant toxin devoid of
proteolytic activities and obtained under the same conditions
as used for LALP. This was to discount the theory that LALP
was contaminated with bacterial proteases during purification
[14]. To ascertain whether LALP displayed any metalloprotease
activity, substrates were incubated with recombinant LALP in
the presence of 5 mM 1,10-phenanthroline (a bivalent chelator)
under the conditions described above. Proteolysis of substrates
was checked by heating the samples at 100 ◦C for 5 min and then
analysing them by SDS/PAGE (7.5% gel for fibronectin, 10% gel
for fibrinogen) under reducing conditions, alongside molecular-
mass markers. Gels were subsequently stained using Coomassie
Blue. Additionally, the proteolytic activity of LALP was assessed
through zymography using SDS/PAGE (12% gel) copolymerized
with gelatin (3 mg/ml). A sample of LALP (2.5 µg) was dissolved
in Laemmli buffer in the absence of reducing agents and then
electrophoresed at 4 ◦C. After electrophoresis, the gel was washed
twice for 30 min in 2.5% (v/v) Triton X-100 to remove SDS and
incubated overnight at 37 ◦C in 50 mM Tris/HCl, pH 7.3, 150 mM
NaCl and 1 mM CaCl2 and then stained with Coomassie Blue.
A clear zone of substrate lysis against a blue background stain
indicated the presence of proteolytic activity.
Statistical analysis
Statistical analyses were performed using ANOVA post-hoc
Tukey test for average comparisons using the GraphPad InStat
program, version 3.00 for Windows 2000. Statistical significance
was established at P < 0.05.
RESULTS
Molecular cloning of an astacin-like metalloprotease
from L. intermedia venom gland
By screening clones of a cDNA library from L. intermedia venom
gland, a cDNA encoding for an astacin-like metalloprotease
toxin was isolated. The cDNA was identified using a protein-
BLAST search, and the putative protein product from this
cDNA was named LALP. Sequence analysis revealed a putative
hydrophobic signal peptide consisting of 16 amino acids [23],
a propeptide of 35 amino acids (deduced from homology
with other astacin-like metalloproteases) [24] and a complete
mature protein of 213 amino acids containing the astacin-family
motifs HEXXHXXGFXHE (the enzymatic catalytic domain) and
MXY (methionine-turn), separated by 44 amino acids [25]. The
complete cDNA sequence of LALP was 900 bp, and the calculated
molecular mass of the full non-active protein was 28.6 kDa, with a
pI of 6.09. Two putative N-glycosylation sites were also identified
(Figure 1).
Phylogenetic relationship to and multiple alignment analysis
of the cDNA-deduced amino acid sequence of LALP with other
astacin family members
To explore further the structural and evolutionary relationships
among the newly identified toxin and other members of the
astacin family, we performed a phylogenetic tree analysis.
Results (Figure 2A) established among LALP and other astacin-
like cloned cDNAs that LALP had the greatest similarity to
NAS-6 (GenBank® accession number NP 503121), a nematode
astacin protease family member, with an overall identity of
35.0% with LALP. On the basis of phylogenetic analysis,
LALP was found to be homologous with other astacin family
members from a variety of species, including human and mouse
c© The Authors Journal compilation c© 2007 Biochemical Society
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Figure 1 Molecular cloning of a metalloprotease toxin LALP from a L. intermedia venom gland cDNA library
Nucleotide and deduced amino acid sequences of cDNA of LALP from L. intermedia venom gland. The predicted signal peptide is underlined in the protein sequence. Annealing positions for primers
used for subcloning into the expression vector are indicated by arrows. Asparagine (in a box) is the first amino acid of the mature protein, with 213 amino acids. The consensus sequences for astacin
family members, HEXXHXXGFXHE, containing the zinc-binding motif is highlighted in another box, and the methionine-turn MXY (highlighted) is also shown. An asterisk indicates the stop codon
(TGA) in bold. The square brackets mark two potential N-glycosylation sites.
meprins, nematode astacin NAS-4, mouse and human ovastacins,
choriolytic hatching enzyme and astacin. Further analysis of
the predicted amino acid sequences additionally confirmed the
presence of conserved features between these different molecules
(specifically for catalytic domains containing the zinc-binding
motif) and strengthened the hypothesis that LALP is an astacin
family member (Figure 2B).
Expression, purification and refolding of LALP
The recombinant metalloprotease, containing a N-terminal
6 × His tag, was expressed in E. coli BL21(DE3)pLysS cells and
was induced for 4 h with 0.05 mM IPTG. Recombinant toxin was
purified by dissolving the insoluble fraction of cell lysates into
6 M guanidinium chloride and subsequently using Ni2+-chelating
chromatography, resulting in a final concentration of LALP of
2.8 mg/l. As depicted in Figure 3, the SDS/PAGE mobility of the
recombinant toxin after denaturation was 29 kDa. The difference
between the predicted molecular mass and SDS/PAGE mobility
for LALP is a consequence of the 6 × His tag fusion peptide.
The purified toxin refolded after dialysis against 10 mM sodium
phosphate buffer, pH 7.4, as described in [21].
CD spectroscopy
CD spectra of the purified recombinant LALP were obtained in
order to analyse the correct refolding for the toxin and determine
some structural details. As depicted in Figure 4, the spectrum
corresponds to a protein with secondary structures of approx.
19% α-helix, 27% β-sheet and 54% other.
Immunological cross-reactivity of recombinant LALP and native
venom toxins
In order to evaluate further the relationship of the purified
recombinant toxin with native venom toxins, we produced
polyclonal antisera against whole-venom toxins or recombinant
LALP and examined these for antigenic cross-reactivity between
the recombinant toxin and whole venom. We performed an
antibody-capture ELISA using antibodies that recognize non-
denatured epitopes on the antigen and an immunoblot to identify
antibodies that recognize denaturation-resistant epitopes on the
antigen. As shown in Figure 5, antibodies against the whole-
venom toxins cross-reacted with the recombinant toxin, and
antibodies against LALP cross-reacted with a native venom toxin
approx. 29 kDa in size, confirming that the whole venom contains
a native protein which is similar to LALP, and this toxin is an
important antigenic determinant.
Effect of LALP on rabbit subendothelial cells
We reported previously the loss of adhesion of some cells,
including rabbit aorta endothelial cells and MDCK (Madin–Darby
canine kidney) cells, after exposure to Loxosceles whole venom
[14,26,27]. This loss of adhesion caused by the presence of the
venom seems to be dependent on proteolysis of extracellular
matrix constituents, which mediate cell adhesion to substrata
[7,8,15,26,28]. To test the relationship between whole-venom-
induced cells’ loss of adhesion and LALP, rabbit subendothelial
cells were treated with purified LALP (5.0 µg/ml) for either 3
or 16 h under the same experimental conditions as for controls
(absence of toxin). As shown in Figure 6, it is possible to observe
loss of adhesion of cells following treatment with the recombinant
toxin: treated cells are fully rounded up, lysed and detached
from culture substrata, whereas the control cells are adherent
and spaced out in a normal manner.
Protease effect of LALP on fibronectin, fibrinogen and gelatin
To evaluate further the role of LALP in the cytotoxic activity of the
venom and to support the indication that proteolysis, loss of cell
adhesion and cell lysis occur due to the presence of purified LALP,
we treated purified fibronectin and fibrinogen (extracellular matrix
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Figure 2 Phylogenetic relationship and multiple alignment analysis of the cDNA-deduced amino acid sequences for the recombinant toxin LALP and other
astacin-like metalloproteases
Sequences were aligned using the ClustalW program (http://www.ebi.ac.uk/CLUSTAL). (A) Phylogenetic relationship of the cloned toxin to other astacin-like metalloproteases based on sequence data
from GenBank®. The tree was constructed with the program ClustalW as described above. Proteins compared (and their GenBank® accession numbers) are as follows: NAS-6 (nematode astacin-6;
NP 503121), hMeprinA (human meprin, α chain; NP 005579), mMeprinA (mouse meprin, α chain; NP 032611), hMeprinB (human meprin, β chain; NP 005916), mMeprinB (mouse meprin, β
chain; NP 032612), NAS-4 (nematode astacin-4; AAB53827), mOvast (mouse ovastacin; CAD61264), hOvast (human ovastacin; CAD61265), HCE (high choriolytic hatching enzyme; C48826),
Astacin (CAB43519), XHE (Xenopus hatching enzyme; BAA14003), BP10 (urchin blastula protease-10; CAA39673), SPAN (AAA30072), hTolloid1 (human tolloid-like 1; O43897), mTolloid (mouse
tolloid-like; NP 033416) and hTolloid2 (human tolloid-like 2; Q9Y6L7). (B) Multiple alignment analysis of the amino acid domains of LALP and the astacin-family-related members as reported by
phylogenetic analysis; identical amino acids are shaded in black, and conservative substitutions are in grey. Arrows in the boxes point to the astacin signature sequence and the methionine-turn.
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Figure 3 Expression and purification of recombinant LALP toxin analysed
by SDS/PAGE (12% gel) under reducing conditions and Coomassie Blue
staining
Lane 1, E. coli BL21(DE3)pLysS cells collected by centrifugation and resuspended in
Laemmli sample buffer 3.5 h prior to induction with 0.025 mM IPTG. Lane 2, the supernatant
of cell lysates induced with 0.025 mM IPTG, obtained by freeze–thawing and sonication
in extraction buffer before affinity chromatography using a Ni-NTA–agarose column.
Lane 3, purified recombinant protein after elution through a Ni-NTA–agarose
column. Molecular-mass standards are shown on the left.
Figure 4 CD spectrum for purified recombinant LALP
Spectra were obtained using toxin in 10 mM sodium phosphate buffer, pH 7.4, at 25◦C.
Secondary structures were estimated using the Dichroprot 2000 1.0.4 software.
molecules that participate in rabbit subendothelial cell adhesion
and vessel wall integrity) with LALP. In addition, we tested
the ability of 1,10-phenanthroline (a bivalent chelator) to block
the enzymatic activity of LALP. As observed, LALP treatment
resulted in the degradation of both fibronectin (Figure 7A) and
fibrinogen (Figure 7B), whereas 1,10-phenanthroline abolished
the proteolytic activity of LALP. A zymogram experiment
containing co-polymerized gelatin further strengthened the
hypothesis that LALP has proteolytic activity (Figure 7C).
DISCUSSION
Proteases of venomous animals have been identified as playing
a major role in the harmful effects observed after bites, such
as haemorrhage, necrosis, cytotoxicity and oedema [29,30]. The
presence of proteolytic activity in the Loxosceles spider venom
was demonstrated previously in electrostimulated venom of L.
reclusa and L. intermedia [7,8,31,32]. The inhibitory effects of
Figure 5 Comparative immunological cross-reactivity of crude venom and
recombinant toxins
(A) Antibody-capture ELISAs were carried out using recombinant toxin LALP (1) or whole-venom
toxins (2) at a concentration of 10 µg/ml, immobilized on a solid phase. Primary antisera against
LALP or whole-venom toxins at the indicated concentrations (x-axis) were incubated for 2 h
at room temperature, and the reaction developed as described in the Experimental section. (B)
Purified recombinant toxin LALP (lane 1) and L. intermedia crude venom (lane 2), each at a
concentration of 5.0 µg were resolved by SDS/PAGE (12.5 % gel) under reducing conditions,
transferred on to nitrocellulose membranes that were exposed to antisera against crude venom
toxins (lane 1) or to LALP (lane 2). Molecular-mass markers are shown on the left (sizes in kDa).
In both cases (ELISA and immunoblotting), cross-reactivity occurred among antibodies against
crude venom toxins and recombinant toxin or antibodies against LALP with native venom toxins.
bivalent metal chelators, such as EDTA and 1,10-phenanthroline,
indicated the presence of metalloproteases in the venom [7,15,16].
The idea of metalloproteases as components of brown spider
venom was strengthened by the venom gland extract possessing
proteolytic activity and a sensitivity to metal chelators. This
eliminated criticism that electrostimulated venom could have been
contamined with spider stomach egesta (containing hydrolytic
enzymes) during extraction [15]. Moreover, the presence of
metalloproteases in the venom of different Loxosceles species,
such as L. intermedia, L. gaucho, L. deserta, L. laeta and
L. rufescens provides evidence for metalloproteases being a
biologically significant and conserved feature of the Loxosceles
species venom [7,9,15,16,33].
The astacin family of metalloproteases, named after the
prototypical digestive enzyme astacin from crayfish, Astacus
astacus, consists of zinc peptidases [34,35]. The astacin family
comprises structurally related digestive, extracellular or cell-
surface-bound proteases that are involved in peptide processing
and play a role in the activation of growth factors, degradation
of polypeptides and the processing of extracellular molecules
[34,36,37]. The zinc-binding domain with the consensus sequence
HEXXHXXGXXHE and the methionine-turn MXY are both key
elements in the astacin family [34,36,37]. Astacin-like enzymes
have been detected in different species, such as human, mouse, rat,
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Figure 6 The effect of LALP on subendothelial cells
Rabbit subendothelial cells were exposed to LALP (5.0 µg/ml) for 3 or 16 h. As a negative control, cells were grown under similar conditions and incubated with a recombinant toxin devoid of
proteolytic activity, but obtained under similar conditions as for LALP. Morphological alterations of cells were observed under an inverted microscope. For LALP toxin-treated cells, cell spreading
appears to be impaired, detachment from the substrate was observed, and cells were round and originated aggregates of debris in a time-dependent manner compared with absence of cytotoxic
effects in the control sample (magnification ×200).
amphibians, fish, sea urchins, insects, molluscs and even bacteria
[36,37], supporting their biological importance.
In the present paper, we have described the identification,
cloning, heterologous expression, purification, immunological
cross-reactivity and function of a metalloprotease toxin, LALP,
from the venom gland of L. intermedia. On the basis of the
predicted amino acid sequence, LALP is thought to be composed
of a domain structure similar to that of astacin metalloproteases
and other astacin-like molecules. The LALP primary structure
includes a signal sequence, a propeptide region, an astacin-like
protease catalytic domain and a characteristic methionine-turn
domain, similar to those of other astacin-like metalloproteases
[34,36,37].
Additionally, several pieces of evidence support the idea that
LALP is an astacin-like metalloprotease. LALP possess an
overall shared identity with astacin and other astacin-like family
members. The molecular mass calculated from the deduced amino
acid sequence (28.6 kDa) and from the SDS/PAGE mobility
(29 kDa) of LALP is very similar to those described previously
for metalloproteases in L. intermedia venom (28–33 kDa) [7,15]
and other Loxosceles venom (30–35 kDa) [33]. The calculated pI
for LALP (pI = 6.09) is very similar to those described for other
astacin-like proteases, such as HMP2 (pI = 5.12), a cnidarian
metalloprotease from Hydra vulgaris [38] and meprin A subunit
(pI = 5.2), which is a vertebrate astacin-like metalloprotease
[39]. Other additional evidence which supports LALP as an
astacin-like metalloprotease comes from its astacin signature
HEXXHXXGFXHE (His92–Glu103), which is the zinc-binding
domain catalytic site, and the methionine-turn MXY (Met148–
Tyr150), an amino acid domain involved in the maintenance of the
conformation of the enzyme [36,40]. Finally, biochemical studies
demonstrated the proteolytic activity of LALP on proteins such
as fibronectin, fibrinogen and gelatin, as well as loss of cellular
adhesion from the culture substrate, which strongly suggests that
this recombinant toxin is a closely related member of the astacin-
like protease family.
Phylogenetic studies based on protein sequence analysis of
several different astacin family members compared with LALP
additionally suggests that LALP is as an astacin-like molecule.
Recombinat LALP was shown to closely resemble astacin, the
prototype member of the atascin-like protease family. The proteins
with the highest amino acid sequence similarities to LALP were
identifed to be NAS-4 and NAS-6, two nematode astacin protease
family members from Caenorhabditis elegans (35.0% of amino
acid identity), followed by SPAN (Strongylocentrotus purpuratus
astacin-like protease) from S. purpuratus (32.0%). Additionally,
LALP is 31.0% similar at the amino acid level with sea urchin
blastula protease BP10. These data suggest that astacin in venom
could have a physiological function in spiders, similar to that
performed by other astacin family members.
Full-length LALP heterogeneously expressed in E. coli cells
was purified using denaturing Ni2+-affinity chromatography and,
using this approach, LALP was eluted in a pure form, as
determined by SDS/PAGE resolution. The recombinant toxin
was refolded followed dialysis against sodium phosphate buffer.
From CD spectra, we can conclude that correct refolding of the
recombinant toxin occurred, and, in addition, the data showed
an estimated percentage for secondary structures of toxin. The
results are typical of folded non-denatured and non-aggregated
proteins.
Characterization of the antigenic cross-reactivity by ELISA and
immunoblotting using antibodies against LALP suggested that
the crude venom contained a similar protein of 29 kDa, which
showed antigenic structural identity with recombinant LALP.
Additionally, antibodies raised against whole-venom toxins
produced a high cross-reactivity with LALP, suggesting that
c© The Authors Journal compilation c© 2007 Biochemical Society
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Figure 7 Proteolytic effect of LALP on fibronectin, fibrinogen and gelatin
Purified fibronectin (A) and fibrinogen (B) were incubated with LALP at 37◦C for 16 h, with a
substrate/toxin ratio of 25:1. For the negative control, protein substrates were incubated under
similar conditions with a recombinant toxin devoid of proteolytic activity, but obtained
under the same conditions for LALP. Samples were subjected to SDS/PAGE (7.5 % gel for
fibronectin; 10 % gel for fibrinogen) under reducing conditions, and gels were stained with
Coomassie Blue. Lane 1, purified substrates without toxin treatment; lane 2, substrates incubated
with whole venom; lane 3, substrates exposed to LALP; lane 4, substrates incubated with LALP
in the presence of 1,10-phenanthroline (5 mM); lane 5, substrates incubated with a recombinant
toxin without proteolytic activity. Positions of fibrinogen A(α), B(β) and γ chains and fibronectin
A and B chains that co-migrate (FN A/B, arrow) are indicated. Molecular-mass markers are
shown on the left. Additionally, the enzymatic function of the recombinant toxin was assessed
through a zymogram copolymerized with gelatin (C). Lane 1 demonstrates the gelatinolytic
activity of LALP, and lane 2 depicts an immunoblot using antibodies against LALP.
epitopes present in this toxin are strong antigenic determinants
and corroborating the presence of this astacin-like toxin in the
venom.
The mechanism by which Loxosceles venom causes gravita-
tional spreading of dermonecrosis and dispersion of other venom
toxins through the body is currently under investigation. The
participation of proteases and hyaluronidases as spreading factors
could be putatively inferred [1]. Hyaluronidases and proteases
have been detected in the venom of many different animals
(snakes, caterpillars, scorpions, bees and spiders [29,41,42,43]).
These enzymes, by degrading extracellular matrix constituents,
can act as spreading factors and facilitate the diffusion of other
venom toxins.
Consistent with the structural characteristics of LALP, the
functional analysis of the recombinant toxin was corroborated
further by the loss of adhesion of endothelial cells on incubation
with LALP, as well as its proteolytic activities on fibronectin,
fibrinogen and gelatin and sensitivity to 1,10-phenanthroline,
which blocked the proteolytic activity of the toxin.
Furtherwork is required toevaluate thebiological significanceof
native astacin-like venom toxin; and to answer the question
of why a protease exists in the venom? We speculate that the
presence of this toxin in the venom represents an adaptation
of spiders to paralyse and kill insect prey as well as to serve
as a defence against predators. Astacin, a digestive enzyme
of the astacin family, shows a phylogenetic link to the LALP
subgroup, which is in agreement with this hypothesis. The
presence of astacin-like metallopeptidases in the digestive fluid of
the spider Argiope aurantia [24] strengthens the idea of astacin-
like molecule expression in venom by spiders and a digestive
function for spider astacin-like metalloproteases. Additionally,
digestive juice components (as is the case with proteases) may
play a role in some of the cutaneous and systemic effects that
occur following brown spider envenomation, as regurgitation
can occur when spiders are crushed up against the skin as part
of the bite process [44]. These proteases could act in synergy
with other venom toxins involved in the deleterious effects after
envenomation.
Additionally, the presence of a protease in venom can represent
a biological mechanism to facilitate the diffusion of other
important venom toxins through the bodies of victims by
rendering tissue structures more permeable, and then acting in
parallel with other biologically active toxins. Finally, a protease
toxin in the venom could be important for the processing of other
peptide-derived toxins that, after proteolysis, are active.
In summary, we have identified a novel brown spider venom
toxin. Moreover, we have cloned, heterogeneously expressed and
purified this toxin, which was characterized as an astacin-like
protease. This toxin degrades extracellular matrix components
and can act as a spreading factor. Together, these results reveal
greater insight into loxoscelism and contribute to the further
understanding of this metalloprotease family,which has now been
identified to be a component of venom.
This work was supported by grants from the CNPq (Conselho Nacional de Desenvolvimento
Cient´ıfico e Tecnolo´gico), CAPES [(Fundac¸a˜o) Coordenac¸a˜o de Aperfeic¸oamento de
Pessoal de Nı´vel Superior], FAPESP (Fundac¸a˜o de Amparo a` Pesquisa do Estado
de Sa˜o Paulo), Fundac¸a˜o Arauca´ria-PR, MEC-SESU (Ministe´rio da Educac¸a˜o e Cultura
do Brasil–Secretaria de Ensino Superior) and SETI-PR (Secretaria de Estado da Cieˆncia,
Tecnologia e Ensino Superior do Parana´), Brazil.
REFERENCES
1 da Silva, P. H., da Silveira, R. B., Appel, M. H., Mangili, O. C., Gremski, W. and Veiga,
S. S. (2004) Brown spider and loxoscelism. Toxicon 44, 693–709
2 Swanson, D. L. and Vetter, R. S. (2006) Loxoscelism. Clin. Dermatol. 24, 213–221
3 Sandidge, J. S. (2003) Arachnology: scavenging by brown recluse spiders. Nature
426, 30
4 Ospedal, K. Z., Appel, M. H., Neto, J. F., Mangili, O. C., Veiga, S. S. and Gremski, W.
(2002) Histopathological findings in rabbits after experimental acute exposure to the
Loxosceles intermedia (brown spider) venom. Int. J. Exp. Pathol. 83, 287–294
5 Elston, D. M., Eggers, J. S., Schmidt, W. E., Storrow, A. B., Doe, R. H., McGlasson, D. and
Fischer, J. R. (2000) Histological findings after brown recluse spider envenomation.
Am. J. Dermatopathol. 22, 242–246
6 Patel, K. D., Modur, V., Zimmerman, G. A., Prescott, S. M. and McIntyre, T. M. (1994) The
necrotic venom of brown recluse induces dysregulated endothelial cell-dependent
neutrophil activation. J. Clin. Invest. 94, 631–642
7 Feitosa, L., Gremski, W., Veiga, S. S., Elias, M. C. Q. B., Graner, E., Mangili, O. C. and
Brentani, R. R. (1998) Detection and characterization of metalloproteinases with
gelatinolytic, fibronectinolytic and fibrinogenolytic activities in brown spider (Loxosceles
intermedia) venom. Toxicon 36, 1039–1051
8 Veiga, S. S., Feitosa, L., Santos, V. L. P., de Souza, G. A., Ribeiro, A. S., Mangili, O. C.,
Porcionatto, M. A., Nader, H. B., Dietrich, C. P., Brentani, R. R. and Gremski, W. (2000)
Effect of Loxosceles intermedia (brown spider) venom on basement membrane structures.
Histochem. J. 32, 397–408
9 Young, A. R. and Pincus, S. J. (2001) Comparison of enzymatic activity from three
species of necrotising arachnids in Australia: Loxosceles rufescens, Badumna insignis
and Lampona cylindrata. Toxicon 39, 391–400
10 da Silveira, R. B., Pigozzo, R. B., Chaim, O. M., Appel, M. H., Dreyfuss, J. L., Toma, L.,
Mangili, O. C., Gremski, W., Dietrich, C. P., Nader, H. B. and Veiga, S. S. (2006)
Molecular cloning and functional characterization of two isoforms of dermonecrotic toxin
from Loxosceles intermedia (brown spider) venom gland. Biochimie 88, 1241–1253
c© The Authors Journal compilation c© 2007 Biochemical Society
An astacin-like metalloprotease toxin 363
11 da Silveira, R. B., Pigozzo, R. B., Chaim, O. M., Appel, M. H., Trevisan, D. S., Dreyfuss,
J. L., Toma, L., Dietrich, C. P., Nader, H. B., Veiga, S. S. and Gremski, W. (2007) Two
novel dermonecrotic toxins LiRecDT4 and LiRecDT5 from brown spider (Loxosceles
intermedia) venom: from cloning to functional characterization. Biochimie 89,
289–300
12 da Silveira, R. B., Chaim, O. M., Mangili, O. C., Gremski, W., Dietrich, C. P., Nader, H. B.
and Veiga, S. S. (2007) Hyaluronidases in Loxosceles intermedia (Brown spider) venom
are endo-β-N-acetyl-D-hexosaminidases hydrolases. Toxicon 49, 758–768
13 Lee, S. and Lynch, K. R. (2005) Brown recluse spider (Loxosceles reclusa) venom
phospholipase D (PLD) generates lysophosphatidic acid (LPA). Biochem. J. 391,
317–323
14 Chaim, O. M., Sade, Y. B., da Silveira, R. B., Toma, L., Kalapothakis, E., Cha´vez-Olo´rtegui,
C., Mangili, O. C., Gremski, W., Dietrich, C. P., Nader, H. B. and Veiga, S. S. (2006) Brown
spider dermonecrotic toxin directly induces nephrotoxicity. Toxicol. Appl. Pharmacol.
211, 64–77
15 da Silveira, R. B., Filho, J. F. S., Mangili, O. C., Veiga, S. S., Gremski, W., Nader, H. B. and
Dietrich, C. P. (2002) Identification of proteases in the extract of venom glands from
brown spider. Toxicon 40, 815–822
16 Zanetti, V. C., da Silveira, R. B., Dreyfuss, J. L., Haoach, J., Mangili, O. C., Veiga, S. S.
and Gremski, W. (2002) Morphological and biochemical evidence of blood
vessel damage and fibrinogenolysis triggered by brown spider venom.
Blood Coagulation Fibrinolysis 13, 135–148
17 Harlow, E. and Lane, D. (1988) Antibodies: A Laboratory Manual, Cold Spring Harbor
Laboratory Press, Cold Spring Harbor
18 Luciano, M. N., Silva, P. H., Chaim, O. M., Santos, V. P., Franco, C. R. C., Soares, M. F. S.,
Zanata, S. M., Mangili, O,C., Gremski, W. and Veiga, S. S. (2004) Experimental evidence
for a direct cytotoxicity of Loxosceles intermedia (brown spider) venom on renal tissue.
J. Histochem. Cytochem. 52, 455–467
19 Engvall, E. and Ruoslahti, E. (1977) Binding of soluble form of fibroblast surface protein,
fibronectin, to collagen. Int. J. Cancer 20, 1–5
20 Altschul, S. F., Madden, T. L., Scha¨ffer, A. A., Zhang, J., Zhang, Z., Miller, W. and
Lippman, D. J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein
database search programs. Nucleic Acids Res. 25, 3389–3402
21 Gmachl, M. and Kreil, G. (1993) Bee venom hyaluronidase is homologous to a membrane
protein of mammalian sperm. Proc. Natl. Acad. Sci. U.S.A. 90, 3569–3573
22 Deleage, G. and Geourjon, C. (1993) An interactive graphic program for calculating the
secondary structure content of proteins from dichroism spectrum. Comput. Appl. Biosci.
2, 197–199
23 Nielsen, H., Engelbrecht, J., Brunak, S. and von Heijne, G. (1997) A neural network
method for identification of prokaryotic and eukaryotic signal peptides and prediction of
their cleavage sites. Int. J. Neural Syst. 8, 581–599
24 Foradori, M. J., Tillinghast, E. K., Smith, J. S., Townley, M. A. and Mooney, R. E. (2006)
Astacin family metallopeptidases and serine peptidase inhibitors in spider digestive fluid.
Comp. Biochem. Physiol. 143, 257–268
25 Bode, W., Gomis-Ruth, F. X. and Sto¨cker, W. (1993) Astacins, serralysins, snake venom
and matrix metalloproteinases exhibit identical zinc-binding environments
(HEXXHXXGXXH and Met-turn) and topologies and shoud be grouped into a common
family, the ‘metzincins’. FEBS Lett. 331, 134–140
26 Veiga, S. S., Zanetti, V. C., Braz, A., Mangili, O. C. and Gremski, W. (2001) Extracellular
matrix molecules as targets for brown spider venom toxins. Braz. J. Med. Biol. Res. 34,
843–850
27 Paludo, K. C., Gremski, L. H., Veiga, S. S., Chaim, O. M., Gremski, W., Buchi, D. F.,
Nader, H. B., Dietrich, C. P. and Franco, C. R. C. (2006) The effect of brown spider venom
on endothelial cell morphology and adhesive structures. Toxicon 47, 844–853
28 Veiga, S. S., Zanetti, V. C., Franco, C. R. C., Trindade, E. S., Porcionatto, M. A., Mangili,
O. C., Gremski, W., Dietrich, C. P. and Nader, H. B. (2001) In vivo and in vitro cytotoxicity
of brown spider venom for blood vessel endothelial cells. Thromb. Res. 102, 229–237
29 Fox, J. W. and Bjarnason, J. B. (1995) Atrolysins: metalloproteinases from Crotalus atrox
venom. Methods Enzymol. 248, 368–387
30 Wu, W. B., Chang, S. C., Liau, M. Y. and Huang, T. F. (2001) Purification, molecular
cloning and mechanism of action of graminelysin I, a snake-venom-derived
metalloproteinase that induces apoptosis of human endothelial cells. Biochem. J. 357,
719–728
31 Eskafi, F. M. and Norment, B. R. (1976) Physiological action of Loxosceles reclusa venom
on insect larvae. Toxicon 14, 7–12
32 Jong, Y. S., Norment, B. R. and Heitz, J. R. (1979) Separation and characterization of
venom components in Loxosceles reclusa. II. Protease enzyme activity. Toxicon 16,
529–537
33 Barbaro, K. C., Knysak, I., Martins, R., Hogan, C. and Winkel, K. (2005) Enzymatic
charactarization, antigenic cross-reactivity and neutralization of dermonecrotic activity of
five Loxosceles spider venoms of medical importance in the Americas. Toxicon 45,
489–499
34 Dumermuth, E., Sterchi, E. E., Jiang, W., Wolz, R., Bond, J. S., Flannery, A. V. and Beynon,
R. J. (1991) The astacin family of metalloendopeptidases. J. Biol. Chem. 266,
21381–21385
35 Sto¨cker, W., Grams, F., Baumann, U., Reinemer, P., Gomis-Ruth, F. X., Mckay, D. B. and
Bode, W. (1995) The metzincins: topological and sequential relations between the
astacins, admalysis, serralysis and matrixins (collagenases) define a superfamily of
zinc-peptidases. Protein Sci. 4, 823–840
36 Bond, J. S. and Beynon, R. J. (1995) The astacin family of metalloendopeptidases.
Protein Sci. 4, 1247–1261
37 Mohrlen, F., Bond, J. S. and Sto¨cker, W. (2004) Other astacin homologues. In Handbook
of Proteolytic Enzymes, 2nd edn (Barrett, A. J., Rawlings, N. D. and Woessner, J. F., eds),
Elsevier, London
38 Yan, L., Kaiyin, F., Zhang, J., Dexter, S. and Sarras, P. (2000) Identification and
characterization of Hydra metalloproteinase 2 (HMP2): a meprin-like astacin
metalloprotease that functions in foot morphogenesis. Development 127, 129–141
39 Jiang, W., Gorbea, C. M., Flannery, A. V., Beynon, R. J., Grant, G. A. and Bond, J. S.
(1992) The subunit of meprin A. Molecular cloning and sequencing, diferential
expression in inbred mouse strains, and evidence for divergent evolution of the α and β
subunits. J. Biol. Chem. 267, 9185–9193
40 Sarras, Jr, M. P. (1996) BMP-1 and the astacin family of metalloproteases: a potencial link
between the extracellular matrix, growth factors and pattern formation. BioEssays 18,
439–442
41 Kreil, G. (1995) Hyaluronidases – a group of neglected enzymes. Protein Sci. 4,
1666–1669
42 Gouveia, A. I. C. B., da Silveira, R. B., Nader, H. B., Dietrich, C. P., Gremski, W. and Veiga,
S. S. (2005) Identification and partial characterization of hyaluronidases in Lonomia
obliqua venom. Toxicon 45, 403–410
43 Kuhn-Nentwig, L., Schaller, J. and Nentwig, W. (2004) Biochemistry, toxicology and
ecology of the venom of the spider Cupiennius salei (Ctenidae). Toxicon 43, 543–553
44 Futrell, J. M. (1992) Loxoscelism. Am. J. Med. Sci. 304, 261–267
Received 15 March 2007/21 May 2007; accepted 29 May 2007
Published as BJ Immediate Publication 29 May 2007, doi:10.1042/BJ20070363
c© The Authors Journal compilation c© 2007 Biochemical Society
